John Doolan, DPM
Foot & Ankle Surgery · New York, NYNPI 1073540480
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 57 manufacturers reported payments, led by Organogenesis Inc. at 32.2% of the total. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 445 payments — averaging $194.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$28K
- Royal Biologics, Inc.$16K
- Polynovo North America LLC$12K
- Gramercy Extremity Orthopedics LLC$8K
- Musculoskeletal Transplant Foundation Inc.$3K
- Stryker$2K
- plus $18K from 51 others
What the payments were for
- Royalty or licence$6791%
- Consulting fees$22,18726%
- Speaking & faculty fees$23,66327%
- Travel & lodging$6,6168%
- Food & beverage$32,35537%
- Education$1,2401%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$11,517
- Novosorb BTM$11,186
- PuraPly$11,088
- Fibrinet$7,322
- PURAPLY WOUND MATRIX$6,944
- MaxxCell$6,000
- AmnioMaxx$5,611
- Dermagraft$3,719
- Puraply/Affinity/NuTech$3,719
- Affinity$3,120
- NOVACHOR$3,120
- NuShield$3,120
- DermaPure$3,075
- Restrata Wound Matrix$1,590
- INTEGRA$1,340
- Arsenal Ankle$1,330
- HOFFMANN$795
- Xperience$708
- BlastX$708
- CoLink$643
How this compares
$86,740 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 24 | $8,260 |
| Celecoxib | 12 | $618 |
| Ammonium Lactate | 20 | $555 |
| Terbinafine Hcl | 60 | $452 |
| Ketoconazole | 37 | $429 |
| Gabapentin | 11 | $190 |
| Diclofenac Sodium | 18 | $156 |
| Mupirocin | 11 | $57 |
| Meloxicam | 19 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $1,421 | $8,26024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
- Matthew ContiNew York$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.